More LUAD patient samples are needed to confirm the prognostic value of SPOCK2, and the function of SPOCK2 in TIIC regulation in cancers as well as its influence on the response to immunotherapy should be verified in future clinical trials. Here, SPOCK2 is linked to cancer.